Carlsmed (NASDAQ:CARL) reported quarterly losses of $(0.40) per share which met the analyst consensus estimate. This is a 80.58 percent increase over losses of $(2.06) per share from the same period last year. The company reported quarterly sales of $13.074 million which beat the analyst consensus estimate of $11.398 million by 14.71 percent. This is a 98.39 percent increase over sales of $6.590 million the same period last year.